Skip to main content
Clinical Trials/NCT03877978
NCT03877978
Completed
Not Applicable

Evaluation of the Incidence of Acute Kidney Attack by Dosing Nephrocheck® in Severe Traumatized Patients

Hospices Civils de Lyon1 site in 1 country196 target enrollmentMay 16, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
Hospices Civils de Lyon
Enrollment
196
Locations
1
Primary Endpoint
Incidence of patients with Nephrocheck score > 0,3
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Acute Kidney Injury (AKI) is a common complication of severe traumatized patients. The diagnosis is often delayed. The Nephrocheck® test allows an earlier assessment of renal stress. The objective of our study is to determine the incidence of risk of AKI in severe traumatized patients within the first 24 hours after their admission to our trauma center. The risk of AKI is defined by a NephroCheck® test >0.3

Registry
clinicaltrials.gov
Start Date
May 16, 2019
End Date
December 2, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age \>18 years
  • trauma patients with ISS ≥15
  • patient admitted to the resuscitation bay of Edouard Herriot Hospital

Exclusion Criteria

  • anuric patient
  • opposition of the patient (or a trusted person) to participate
  • pregnant or lactating woman
  • age \<18 years

Outcomes

Primary Outcomes

Incidence of patients with Nephrocheck score > 0,3

Time Frame: Up to 24 hours after trauma

Incidence of severe traumatized patient at risk of AKI as defined by Nephrocheck test score \> 0,3 within the first 24 hours after admission

Study Sites (1)

Loading locations...

Similar Trials